Membranous nephropathy in the UK Biobank.
<h4>Background</h4>Despite MN being one of the most common causes of nephrotic syndrome worldwide, its biological and environmental determinants are poorly understood in large-part due to it being a rare disease. Making use of the UK Biobank, a unique resource holding a clinical dataset...
Main Authors: | Patrick Hamilton, Kieran Blaikie, Stephen A Roberts, Matthew Gittins, Mallory L Downie, Sanjana Gupta, Catalin Voinescu, Durga Kanigicherla, Horia Stanescu, Robert Kleta, Paul Brenchley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0281795 |
Similar Items
-
Membranous nephropathy in the UK Biobank
by: Patrick Hamilton, et al.
Published: (2023-01-01) -
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
by: Omar Ragy, et al.
Published: (2023-01-01) -
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
by: Omar Ragy, et al.
Published: (2023-01-01) -
A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous Nephropathy
by: Sanjana Gupta, et al.
Published: (2023-03-01) -
Long-term safety, clinical and immunological outcomes in Primary Membranous Nephropathy with Severe Renal Impairment treated with cyclophosphamide and steroid-based regimen
by: Omar Ragy, et al.
Published: (2023-02-01)